[ET Net News Agency, 15 April 2024] IMMUNEONCO-B (01541) rose 21% to HK$17.4, breaking
above the 20-D SMA of HK$15.569.
It hits an intra-day high of HK$17.5, and an intra-day low of HK$14.34. The total shares
traded was 199,200, with a value of HK$3.07m. The active buy/sell ratio is 83:17, with net
buying turnover of HK$1.93m. YUE XIU SEC accounts for greatest net responsive buying
turnover of HK$14,958, with volume weighted average price of HK$16.62. CHINA INV INFO
accounts for greatest net responsive selling turnover of HK$615,502, with volume weighted
average price of HK$15.565.
Basic Information
=================
-----------------------------------
Nominal 17.400 % Chg +21.00%
High 17.500 Low 14.340
Shares Tr 199,200 Turnover 3.07m
10-D SMA 15.148 %H.V 82.341
20-D SMA 15.569 VWAP 15.399
50-D SMA 18.476 RSI14 53.452
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 83:17, with net buying
turnover of HK$1.93m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 17.40 +21.00
GENSCRIPT BIO (01548) 12.06 -5.49
INNOVENT BIO (01801) 35.80 -4.15
EVEREST MED-B (01952) 24.45 -6.50
LAEKNA-B (02105) 7.73 +60.71
SIRNAOMICS-B (02257) 7.75 +19.23
WUXI BIO (02269) 13.64 -1.87
TIGERMED (03347) 32.25 Unchanged
AKESO (09926) 47.95 -3.13
REMEGEN (09995) 28.90 -10.39
---------------------------------------------
(ed)